Who are Alexandria Real Estate Equities, Inc.'s major customers?

Alexandria Real Estate Equities, Inc. (ARE) key customers include: AMGEN-INC, VAXCYTE-INC. View the full customer network at chainsifter.com/chain/ARE.

What sector is Alexandria Real Estate Equities, Inc. in?

Alexandria Real Estate Equities, Inc. (ARE) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

ARE Supply Chain: Alexandria Real Estate Equities, Inc. Suppliers & Customers

0Suppliers

2Customers

2Debt Items

20Related Chains

Alexandria Real Estate Equities, Inc. Suppliers

No suppliers on recordAlexandria Real Estate Equities, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Alexandria Real Estate Equities, Inc. Customers

Ticker	Name	Confidence	Evidence
AMGEN-INC	AMGEN-INC	90%	Annual rental revenue and RSF include 100% of each property managed by us in North America.
VAXCYTE-INC	VAXCYTE-INC	90%	Annual rental revenue and RSF include 100% of each property managed by us in North America.

Alexandria Real Estate Equities, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ARE-DEBT	Debt stack $12.9B	90%	Market cache reports total debt of $12.9B.
ARE-DEBT-7188	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2010-12-31.

Alexandria Real Estate Equities, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Alexandria Real Estate Equities, Inc..

Alexandria Real Estate Equities, Inc. Ownership

Holder	Name	Confidence	Evidence
ARE-OWNER-MORGAN-STANLEY	MORGAN STANLEY	90%	13F overlay lists MORGAN STANLEY as top holder; 6 tracked holders.

Alexandria Real Estate Equities, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
PSNL	Personalis, Inc.	100.00	2
DYN	Dyne Therapeutics, Inc.	100.00	2
CCEP	Coca-Cola Europacific Partners PLC	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
ALXO	ALX Oncology Holdings Inc.	100.00	2
EDSA	Edesa Biotech, Inc.	100.00	2
ANRO	Alto Neuroscience, Inc.	100.00	2
WHWK	Whitehawk Therapeutics, Inc.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
BLRX	BioLineRx Ltd.	100.00	2
BNBX	BNB Plus Corp.	100.00	2
CTNM	Contineum Therapeutics, Inc.	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
AZN	AstraZeneca PLC	100.00	2
IMMP	Immutep Limited	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
CYTK	Cytokinetics, Incorporated	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
CBIO	Crescent Biopharma, Inc.	100.00	2
DBVTF	DBV TECHNOLOGIES	100.00	2

Alexandria Real Estate Equities, Inc. Supply Chain